Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zeo ScientifiX, Inc.ZEOX · Entity 8005 | Director · Chief Medical Officer | June 10, 2026 | June 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zeo ScientifiX, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2036-06-10 | Direct | 625,000 |
Reported balance
After 2026-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 625,000 · Balance 625,000 F1: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2036-06-10 | Direct | 625,000 |
Reported balance
After 2026-06-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-10 · Grant · Acquired 625,000 · Balance 625,000 F2: Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan.
F2: Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 20:24 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 625,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001829126-26-006450 · ownership.xml · derivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2036-06-10 F2 · kind: Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. F2 · derivative.exercise_date: Represents the grant of stock options to purchase shares of the Issuer's common stock under the 2021 Plan. The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:24 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 625,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001829126-26-006450 · ownership.xml · derivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2036-06-10 F1 · kind: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. F1 · derivative.exercise_date: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 21:05 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-26-000367 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 578,021 F1 · kind: Represents the grant of restricted shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The shares vest 50% on the 8th month anniversary of the grant date and the remaining 50% on the 12th month anniversary. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 55,000 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0001829126-25-003571 · ownership.xml · derivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2030-05-08 F1 · kind: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. F1 · derivative.exercise_date: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. Read SEC document |
| July 11, 2024 Filed Jul 15, 2024 21:21 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 125,000 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001829126-24-004805 · ownership.xml · derivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-07-11 F1 · kind: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. F1 · derivative.exercise_date: Represents the grant of stock options under the issuer's 2021 Equity Incentive Plan (the "Plan"). The options vest in equal monthly installments over a period of eighteen (18) months from the grant date and are subject to the terms of the Plan. Read SEC document |
| August 19, 2022 Filed Aug 24, 2022 20:54 UTC | Zeo ScientifiX, Inc. OCEL · Entity 8005 | GrantWarrant to Purchase Common Stock · Derivative | 3,150,000 | Not disclosed Strike: $0.02 | Not disclosed |
DisclosureSEC source: 0001829126-22-016140 · ownership.xml · derivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,150,000 Underlying: Common Stock · 3,150,000 shares Expires 2032-08-19 F1 · kind: The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid consulting fees due him as of July 31, 2022 and to terminate the consulting arrangement with the Issuer. F1 · price: The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid consulting fees due him as of July 31, 2022 and to terminate the consulting arrangement with the Issuer. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:51 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | OtherCommon Stock | 5,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005203 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,604,187 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under (i) the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan and (4,500,000 shares) (ii) the contractual arrangement of the Reporting Person with the Company (500,000 shares) for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| October 29, 2021 Filed Nov 3, 2021 01:51 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | OtherCommon Stock | 5,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005203 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,604,187 F1 · kind: The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under (i) the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan and (4,500,000 shares) (ii) the contractual arrangement of the Reporting Person with the Company (500,000 shares) for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. F2 · price: Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 01:01 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 9,955 | $0.14 | $1,373.79 |
DisclosureSEC source: 0001683168-21-002665 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,604,187 Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 01:50 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 21,079 | $0.15 | $3,161.85 |
DisclosureSEC source: 0001683168-21-002591 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,614,142 Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 01:50 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 40,375 | $0.15 | $6,177.38 |
DisclosureSEC source: 0001683168-21-002591 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,635,221 Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:50 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.16 | $8,000.00 |
DisclosureSEC source: 0001683168-21-002591 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,675,596 Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:50 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 32,000 | $0.14 | $4,480.00 |
DisclosureSEC source: 0001683168-21-002591 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,725,596 Read SEC document |
| June 11, 2021 Filed Jun 12, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.14 | $7,000.00 |
DisclosureSEC source: 0001683168-21-002504 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,757,596 Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.14 | $7,100.00 |
DisclosureSEC source: 0001683168-21-002504 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,807,596 Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.16 | $7,750.00 |
DisclosureSEC source: 0001683168-21-002504 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,857,596 Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.14 | $7,150.00 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 7 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,907,596 Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.13 | $6,250.00 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 6 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,957,596 Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.12 | $6,200.00 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 5 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,007,596 Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.13 | $6,250.00 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,057,596 Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 41,772 | $0.14 | $5,722.76 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,107,596 Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 9,028 | $0.14 | $1,227.81 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,149,368 Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 01:49 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.14 | $7,000.00 |
DisclosureSEC source: 0001683168-21-002430 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,158,396 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 40,000 | $0.16 | $6,400.00 |
DisclosureSEC source: 0001683168-21-002360 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,208,396 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.17 | $8,650.00 |
DisclosureSEC source: 0001683168-21-002360 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,248,396 Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.19 | $9,600.00 |
DisclosureSEC source: 0001683168-21-002360 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,298,396 Read SEC document |
| May 28, 2021 Filed May 29, 2021 01:44 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 42,749 | $0.18 | $7,652.07 |
DisclosureSEC source: 0001683168-21-002286 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,348,396 Read SEC document |
| May 27, 2021 Filed May 29, 2021 01:44 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 7,251 | $0.18 | $1,305.18 |
DisclosureSEC source: 0001683168-21-002286 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,391,145 Read SEC document |
| May 27, 2021 Filed May 29, 2021 01:44 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.18 | $9,000.00 |
DisclosureSEC source: 0001683168-21-002286 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,398,396 Read SEC document |
| May 26, 2021 Filed May 29, 2021 01:44 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 40,000 | $0.19 | $7,720.00 |
DisclosureSEC source: 0001683168-21-002286 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,448,396 Read SEC document |
| May 25, 2021 Filed May 26, 2021 01:46 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.20 | $10,000.00 |
DisclosureSEC source: 0001683168-21-002231 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,488,396 Read SEC document |
| May 25, 2021 Filed May 26, 2021 01:46 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.19 | $9,700.00 |
DisclosureSEC source: 0001683168-21-002231 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,538,396 Read SEC document |
| May 24, 2021 Filed May 26, 2021 01:46 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.18 | $9,000.00 |
DisclosureSEC source: 0001683168-21-002231 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,588,396 Read SEC document |
| May 21, 2021 Filed May 26, 2021 01:46 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 6,504 | $0.19 | $1,203.24 |
DisclosureSEC source: 0001683168-21-002231 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,638,396 Read SEC document |
| May 20, 2021 Filed May 21, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 100,000 | $0.19 | $19,000.00 |
DisclosureSEC source: 0001683168-21-002142 · ownership.xml · nonDerivative · entry 5 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,644,900 Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 20,000 | $0.20 | $4,000.00 |
DisclosureSEC source: 0001683168-21-002142 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,744,900 Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 5,000 | $0.20 | $1,000.00 |
DisclosureSEC source: 0001683168-21-002142 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,764,900 Read SEC document |
| May 19, 2021 Filed May 21, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.24 | $12,150.00 |
DisclosureSEC source: 0001683168-21-002142 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,769,900 Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.22 | $11,000.00 |
DisclosureSEC source: 0001683168-21-002142 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,819,900 Read SEC document |
| May 17, 2021 Filed May 18, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 25,000 | $0.20 | $5,000.00 |
DisclosureSEC source: 0001683168-21-002077 · ownership.xml · nonDerivative · entry 6 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,869,900 Read SEC document |
| May 17, 2021 Filed May 18, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.20 | $10,200.00 |
DisclosureSEC source: 0001683168-21-002077 · ownership.xml · nonDerivative · entry 5 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,894,900 Read SEC document |
| May 14, 2021 Filed May 18, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.24 | $12,050.00 |
DisclosureSEC source: 0001683168-21-002077 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,944,900 Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 33,987 | $0.25 | $8,496.75 |
DisclosureSEC source: 0001683168-21-002077 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,994,900 Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 7,516 | $0.25 | $1,848.94 |
DisclosureSEC source: 0001683168-21-002077 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,028,887 Read SEC document |
| May 13, 2021 Filed May 18, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 8,597 | $0.27 | $2,321.19 |
DisclosureSEC source: 0001683168-21-002077 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,036,403 Read SEC document |
| May 12, 2021 Filed May 13, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.27 | $13,250.00 |
DisclosureSEC source: 0001683168-21-001931 · ownership.xml · nonDerivative · entry 4 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,045,000 Read SEC document |
| May 11, 2021 Filed May 13, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 100 | $0.26 | $26.00 |
DisclosureSEC source: 0001683168-21-001931 · ownership.xml · nonDerivative · entry 3 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,095,000 Read SEC document |
| May 11, 2021 Filed May 13, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.35 | $17,500.00 |
DisclosureSEC source: 0001683168-21-001931 · ownership.xml · nonDerivative · entry 2 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,095,100 Read SEC document |
| May 10, 2021 Filed May 13, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 50,000 | $0.27 | $13,500.00 |
DisclosureSEC source: 0001683168-21-001931 · ownership.xml · nonDerivative · entry 1 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,145,100 Read SEC document |
| May 07, 2021 Filed May 8, 2021 01:45 UTC | Zeo ScientifiX, Inc. BPSR · Entity 8005 | SaleCommon Stock | 5,708 | $0.26 | $1,455.54 |
DisclosureSEC source: 0001683168-21-001827 · ownership.xml · nonDerivative · entry 6 Shapiro George Craig · CIK 0001804141 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,195,100 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.